These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3935408)

  • 1. Re: serious side effects of oxamniquine during the treatment of Schistosoma mansoni in Kenya.
    Okela GB
    East Afr Med J; 1985 Jul; 62(7):433. PubMed ID: 3935408
    [No Abstract]   [Full Text] [Related]  

  • 2. Serious side effects of oxamniquine during the treatment of Schistosoma mansoni in Kenya.
    Chunge CN; Kimani RG; Gachihi G; Mkoji G; Kamau T; Rashid JR
    East Afr Med J; 1985 Jan; 62(1):3-4. PubMed ID: 4006813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurotoxicity of oxamniquine in the treatment of human Schistosoma mansoni infection].
    de Carvalho SA; Shikanai-Yasuda MA; Amato Neto V; Shiroma M; Luccas FJ
    Rev Inst Med Trop Sao Paulo; 1985; 27(3):132-42. PubMed ID: 3938063
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures associated with oxamniquine therapy.
    Stokvis H; Bauer AG; Stuiver PC; Malcolm AD; Overbosch D
    Am J Trop Med Hyg; 1986 Mar; 35(2):330-1. PubMed ID: 3082231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxamniquine and fever.
    Jordan P
    Br Med J; 1979 Nov; 2(6201):1366-7. PubMed ID: 519455
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and toxicity of oxamniquine in the treatment of Schistosoma mansoni infections, with particular reference to electroencephalographic abnormalities.
    Krajden S; Keystone JS; Glenn C
    Am J Trop Med Hyg; 1983 Nov; 32(6):1344-6. PubMed ID: 6650735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of chromosomes of schistosomiasis patients under oxaminiquine (UK 4271) treatment.
    Monsalve MV; Frota-Pessoa O; Campos AM; Sette H
    J Toxicol Environ Health; 1976 Jul; 1(6):1023-6. PubMed ID: 966313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in children in Ethiopia.
    Ayele T
    East Afr Med J; 1986 Apr; 63(4):291-4. PubMed ID: 3089756
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac arrhythmia with oral oxamniquine use in the schistosomiasis mansoni treatment].
    Guitti JC; Gordan LN; Baldy JL
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):585-7. PubMed ID: 7997766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

  • 13. Seizures and electroencephalograph changes associated with oxamniquine therapy.
    Keystone JS
    Am J Trop Med Hyg; 1978 Mar; 27(2 Pt 1):360-2. PubMed ID: 646029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of clinical experience with oxamniquine.
    Foster R
    Trans R Soc Trop Med Hyg; 1987; 81(1):55-9. PubMed ID: 3127959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxamniquine treatment for schistosomal polyposis: a 1-2 year follow-up study.
    el-Masry NA; Farid Z; Bassily S; Kilpatrick ME; Watten RH; Girgis NI
    J Trop Med Hyg; 1986 Feb; 89(1):19-21. PubMed ID: 3091853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fifteen-month study on the efficacy of a single 15 mg/kg dose of oxamniquine (Vansil) in Schistosoma mansoni in an endemic area.
    Nozais JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):52-7, 168-74. PubMed ID: 6256843
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N; Rocha RS
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):310-4. PubMed ID: 6762634
    [No Abstract]   [Full Text] [Related]  

  • 20. A field evaluation of three dose levels of oxamniquine in Gezira--Sudan.
    Abdel-Rahim IM; Haridi AA; Abdel-Hameed AA
    East Afr Med J; 1988 Nov; 65(11):771-7. PubMed ID: 3150352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.